Annual Shareholders Equity
-$489.10 M
+$97.89 M+16.68%
December 31, 2024
Summary
- As of March 7, 2025, IBRX annual stockholders equity is -$489.10 million, with the most recent change of +$97.89 million (+16.68%) on December 31, 2024.
- During the last 3 years, IBRX annual shareholders equity has fallen by -$246.93 million (-101.96%).
- IBRX annual shareholders equity is now -308.23% below its all-time high of -$119.81 million, reached on December 31, 2020.
Performance
IBRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$489.10 M
+$256.05 M+34.36%
December 31, 2024
Summary
- As of March 7, 2025, IBRX quarterly stockholders equity is -$489.10 million, with the most recent change of +$256.05 million (+34.36%) on December 31, 2024.
- Over the past year, IBRX quarterly shareholders equity has increased by +$256.05 million (+34.36%).
- IBRX quarterly shareholders equity is now -308.23% below its all-time high of -$119.81 million, reached on December 31, 2020.
Performance
IBRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IBRX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +16.7% | +34.4% |
3 y3 years | -102.0% | +34.4% |
5 y5 years | - | +34.4% |
IBRX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -102.0% | +16.7% | -102.0% | +34.4% |
5 y | 5-year | -308.2% | +16.7% | -308.2% | +34.4% |
alltime | all time | -308.2% | +16.7% | -308.2% | +34.4% |
ImmunityBio Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$489.10 M(-16.7%) | -$489.10 M(-34.4%) |
Sep 2024 | - | -$745.15 M(+6.7%) |
Jun 2024 | - | -$698.39 M(+0.9%) |
Mar 2024 | - | -$692.01 M(+17.9%) |
Dec 2023 | -$586.99 M(+31.2%) | -$586.99 M(+42.6%) |
Sep 2023 | - | -$411.72 M(-35.9%) |
Jun 2023 | - | -$642.12 M(+21.4%) |
Mar 2023 | - | -$528.98 M(+18.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | -$447.33 M(+84.7%) | -$447.33 M(+4.8%) |
Sep 2022 | - | -$426.70 M(+1.6%) |
Jun 2022 | - | -$419.81 M(+25.1%) |
Mar 2022 | - | -$335.64 M(+38.6%) |
Dec 2021 | -$242.17 M(+102.1%) | -$242.17 M(+28.5%) |
Sep 2021 | - | -$188.50 M(+19.3%) |
Jun 2021 | - | -$157.94 M(-15.0%) |
Mar 2021 | - | -$185.79 M(+55.1%) |
Dec 2020 | -$119.81 M | -$119.81 M |
FAQ
- What is ImmunityBio annual stockholders equity?
- What is the all time high annual shareholders equity for ImmunityBio?
- What is ImmunityBio annual shareholders equity year-on-year change?
- What is ImmunityBio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ImmunityBio?
- What is ImmunityBio quarterly shareholders equity year-on-year change?
What is ImmunityBio annual stockholders equity?
The current annual shareholders equity of IBRX is -$489.10 M
What is the all time high annual shareholders equity for ImmunityBio?
ImmunityBio all-time high annual stockholders equity is -$119.81 M
What is ImmunityBio annual shareholders equity year-on-year change?
Over the past year, IBRX annual stockholders equity has changed by +$97.89 M (+16.68%)
What is ImmunityBio quarterly stockholders equity?
The current quarterly shareholders equity of IBRX is -$489.10 M
What is the all time high quarterly shareholders equity for ImmunityBio?
ImmunityBio all-time high quarterly stockholders equity is -$119.81 M
What is ImmunityBio quarterly shareholders equity year-on-year change?
Over the past year, IBRX quarterly stockholders equity has changed by +$256.05 M (+34.36%)